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Abstract
This study indicates that embryonic stem cells [ESCs] cultured with retinoic acid and activin A significantly upregulate the
miRNA let-7e. This specific miRNA modulates the Wnt pathway and the expression of early nephrogenic markers under
these differentiation conditions. The differentiation markers WT1, Pax2 and Wnt4 were downregulated when miRNA let-7e
was silenced, thus indicating the role of miRNA let-7e in the differentiation process. PKCb, GSK3b phosphorylation (GSK3bP)
and b-catenin expression was reduced in differentiated cells and reversed by miRNA let-7e silencing. Addition of a PKCb
inhibitor to the miRNA let-7e silenced cells abolished let-7e-derived effects in differentiation markers, and reversed the
increase in GSK3bP and b-catenin, thus indicating that miRNA let-7e is involved in differentiation via the modulation of
GSK3b phosphorylation and b-catenin production.
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Introduction
Mouse embryonic stem cells (mESCs) isolated from blastocysts
are pluripotent cells with unlimited self-renewal capacity and the
potential to generate all the cell types of the three germinal layers.
These cells have been used to generate highly specialized cells and
tissues in vitro such as pancreatic cells [1], motor neurons [2],
hematopoietic cells [3] and renal cells [4].
Nowadays much research is trying to develop renal precursors
that could integrate and regenerate damaged kidney. From our
point of view it is important to study the possible mechanisms
involved in ESCs differentiation because these cells could be a
potential source of these precursors.
mESCs in cell culture remain undifferentiated in the presence of
leukemia inhibitory factor (LIF) [5]. Withdrawal of LIF, gives rise
to embryoid bodies (EBs) formation that can be differentiated
toward renal lineage using activin A, retinoic acid and BMP7 [6].
Retinoic acid and activin A stimulate expression of early
intermediate mesoderm markers on the basis of pioneering work
in Xenopus embryos [7,8] and in murine embryonic stem cells in a
more recent study [9].
Stem cell differentiation towards renal lineage is associated with
the sequential expression of different marker genes characteristic
of early kidney development.
Pax2 is one of the earliest markers expressed in the intermediate
mesoderm from where takes place the formation of the kidney.
Pax2 and Wt1 are subsequently expressed in the metanephric
mesenchyme and are two genes characteristic for initiation of
nephrogenesis [9]. This gene expression is then followed by the
secretion of many additional secreted factors, including Wnt4 and
Wnt9b which are expressed in the condensing mesenchyme
[10,11] and both are involved in the formation of epithelia [11].
Following that, the presence of Notch2 directs cells primarily to
the proximal tubule fate [11].
Wnt/b-catenin signalling is essential during kidney development
as well as in cell differentiation towards renal lineage [12,13].
Furthermore, Wnt is also believed to stimulate ESCs proliferation
and maintain pluripotency [14], and its improper regulation is
associated with cyst formation in the kidney [15]. Wnt/b-catenin
activation should therefore be tightly regulated.
b-catenin production is dependent on Glycogen synthase kinase
3 beta (GSK3b) phosphorylation. GSK3b is a ubiquitously
expressed, highly conserved serine/threonine protein kinase found
in all eukaryotes and serves as a downstream regulatory switch for
the Wnt signalling pathway [16]. Serine Phosphorylation of
GSK3b is performed by protein kinase C beta (PKCb) [17,18].
microRNAs (miRNAs) are short noncoding RNAs of ,22 nt
that post-transcriptionally regulate gene expression through the
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39untranslated regions (39UTRs) of their target mRNAs. miRNAs
are able to regulate the expression of numerous mRNAs, some of
them belonging to critical pathways during differentiation such as
the Wnt Pathway [19]. Some of these miRNAs, as is the case of
the miRNA let-7 family, regulate cell proliferation and differen-
tiation during development in different species [20]. Specifically,
let-7e was detected in the adult kidney [21] and recent studies have
started to investigate its role in renal cancer [a state of cell
dedifferentiation], outlining that let-7e is downregulated and
associated with metastasis and poor prognosis [22].
We hypothesized that miRNA let-7e was determinant in stem
cell differentiation and expression of early nephrogenic mar-
kers.Therefore, EBs were differentiated using retinoic acid and
activin A, a classical combination that promote the expression of
genes characteristic of the intermediate mesoderm. miRNA let-7e
silencing decreased the expression of these differentiation markers.
In addition, since PKCb is an inductor of GSK3b phosphorylation
(GSK3bP), we hypothesized that miRNA let-7e could inhibit the
formation of PKCb protein that in turn decreases serine
phosphorylation and the negative regulation of GSK3b activity,
destabilizing b-catenin during the differentiation process in
mESCs.
Here we present our findings concerning the involvement of
miRNA let-7e in stem cell differentiation via the modulation of
GSK3b phosphorylation and b-catenin production.
Materials and Methods
Ethics Statement
This study has been approved by the bioethics committee of
CSIC (Spanish National Research Council).
Culture of the Undifferentiated mESCs
All chemical reagents were obtained from Millipore unless
otherwise indicated. mESCs (C57BL/6) were grown in DMEM
(EmbryoMaxH ES Cell Qualified DMEM) supplemented with
15% FBS, 1% non-essential nucleotides, 1% non-essential amino
acids, 0.1 mM 2-Mercaptoetanol, 2 mM L-Glutamine, 100 units/
ml Penicillin 100 mg/ml Streptomycin and 103 units/ml mouse
LIF (mLIF) on a 0.1% gelatine-coated tissue culture plate with a
feeder layer of Premier mouse embryonic fibroblasts (PMEF-H).
mESCs were dissociated with 0.05% trypsin-EDTA and trans-
ferred to a Petri dish to induce embryoid body (EB) formation.
Induction of EBs Differentiation
EBs suspension was transferred to culture flasks coated with
0.1% gelatine and cultured for an additional 1 to 10 days with the
described medium without mLIF and with presence or absence of:
retinoic acid (ATRA) (Sigma-Aldrich) 0.1 mM and activin A
Sigma-Aldrich)10 ng/ml.
Transfection
Transfection of EBs with 62.5 nM LNA-antiLet-7e oligonucle-
otide: 59–ACTATACAACCTCCTACCTC-39 (Exiqon) or the
respective control antimiR 59-AGAGCTCCCTTCAATCCAAA-
39 (Exiqon) were carried out using LipofectamineTM 2000
(Invitrogen), according to the manufacturer’s protocol. Medium
was replaced after 6 h of transfection.
Other Treatments
Protein kinase C inhibitor Go¨ 6983 (Sigma-Aldrich), inhibits
PKCb isozyme and was administered (7 nM) at the same time as
the LNA-antiLet-7e (6 h).
6-bromoindirubin-3’-oxime (BIO), the specific pharmacological
inhibitor of glycogen synthase kinase-3 (GSK-3) was administered
(5 mM) for 24 h.
Experimental Groups
EBs were cultured for 1 to 10 days under different conditions:
N I) CONTROL.- EBs treated with control antimiR
N II) DIF.- EBs cultured with addition of 0.1 mM retinoic acid
(ATRA) and 10 ng/ml activin A and treated with control
antimiR.
N III) DIF- Let-7e.- Same as group II but let-7e silenced with
LNA-antiLet-7e.
N IV) DIF- Let-7e+PKCbi.- Same as group III but treated with
the protein kinase C inhibitor Go¨ 6983 (7 nM) for 6 h.
N V) DIF+BIO.- Same as group II but treated plus 5 mM BIO
(inhibitor of GSK3) for 24 h (from day 9 to day 10).
RNA Extraction Reverse Transcription mRNA and RT-PCR
Total RNA was extracted using TRIZOL reagent (Invitrogen)
and 1 mg was reverse transcribed using an iScriptTM cDNA
synthesis kit (Bio-Rad). Quantitative reverse transcription PCRs
were performed using the TaqMan Universal PCR Master Mix
(Applied Biosystems) and primers previously validated and
provided by Applied Biosystems: Pax2 (Mm01217939_m1),
WT1 (Mm00460570_m1), Wnt9b (Mm00457102_m1), Wnt4
(Mm01194003_m1) and Notch2 (Mm00803077_m1). Results
were normalized to glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) (Mm99999915_g1).
miRNA Microarray
A miRNA PCR Array System (SA Biosciences) that included
specific primers for 88 different mouse miRNAs was performed
according the manufacturer’s instructions. RNA extracted from a
pool of four control EBs (Control EBs d8) and a pool of 4
differentiated EBs (DIF EBs d8) were profiled. The resulting data
was normalized to the average of the four small nuclear
housekeeping RNAs (snoRNA251, snoRNA202, snoRNA142
and U6 snRNA). Results have been deposited in the Array
Express database, accession number (E-MTAB-1468). In order to
validate the expression levels obtained in the microarray
experiments, we used quantitative real-time RT-PCR, and
Northern Blot analysis.
Northern Blot
miRNA Northern Blot Assay Kit (Signosis) was performed using
5 mg total RNA according to the manufacturer’s protocol using a
complementary probe to miRNA mmu-let-7e.
Reverse Transcription and RT-PCR microRNA
Total RNA was extracted as described previously. Specific
reverse transcription for miRNA mmu-let-7e and U6 small
nuclear RNA (U6 snRNA) was performed using TaqManH
microRNA Assay (Applied Biosystems). The RT-PCR was
performed using the TaqManH Universal PCR Master Mix
(Applied Biosystems) and results were normalized to U6 snRNA.
Western Blot
EBs were lysed in buffer 7 M Urea, 2 M Tiourea, 4% [w/v]
CHAPS, 40 mM Tris-base, pH 7.4, containing 1 mM PMSF,
10 mM DTT, 0.1% protease inhibitor cocktail (Sigma-Aldrich)
and 1% phosphatase inhibitor cocktail 3 (Sigma-Aldrich) at 4uC.
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Measurement of protein concentration was done using Bradford
[Bio-Rad]. 100 mg of proteins were electrophoresed on SDS-10%
polyacrylamide gel and transferred to nitrocellulose membranes
which were subsequently blocked with 5% BSA in 0.06% Tween-
TRIS-buffered saline for 1 h at RT (or at 4uC for GSK3bP).
Membranes were incubated overnight at 4uC with the following
primary antibodies: Phospho-GSK3b-S (1:500) (Abgent), PKCbI
(1:500) (Santa Cruz), Anti-b-catenin (1:400) (BD Bioscience), Pax2
(1:350) (Santa Cruz), Wt1 (1:250) (Santa Cruz) washed with
TTBS, and incubated for 1 h at RT with horseradish peroxidase-
conjugated anti-rabbit IgG (1:2.000) (Sigma-Aldrich) for GSK3bP,
PKCbI and WT1 with anti-mouse IgG (1:2.000) (Sigma-Aldrich)
for b-catenin or with anti-goat IgG (1:2.500) (Sigma-Aldrich) for
Pax2, followed by ECL-detection. Equal protein loading was
verified by immunoblotting for b-actin (Sigma-Aldrich).
Statistical Analysis
Data are expressed as means 6 SE. Means of different groups
were compared using one way ANOVA. The Student-Newman-
Keuls test was used for the evaluation of significant differences
between groups. The existence of significant differences was
already assumed when P,0.05.
Results
ATRA and Activin A Treatment Differentiates EBs and
Promote the Expression of Early Nephrogenic Markers
and miRNA let-7e
Figure 1A shows the efficiency of the treatment applied to
embryoid bodies (EBs) to express intermediate mesoderm and
methanephric mesenchyme markers. mRNA expression of Pax2
(intermediate mesoderm) and Pax2, WT1, Wnt9b, Wnt4, Notch2
Figure 1. Embryoid bodies (EBs) cultured with a combination of ATRA and activin A express markers of intermediate mesoderm
and metanephric mesenchyme and overexpresses the miRNA let-7e. A) Total RNA was extracted from EBs cultured for 1 to 10 days with
ATRA and activin A [black columns] or without factors [white columns] and assayed for gene specific expression (Pax2, WT-1, Wnt4, Wnt9b and
Notch2) by RT-PCR. Data shown starts on day 5, the time when expression of genes tested starts to be significantly upregulated. n = 4. Data are
means6S.D [*] P,0.05 vs. non treated EBs (white columns) and normalized to GAPDH; B) Western blot analysis of Pax2 and WT1 in cell lysates of EBs
cultured for 8 days. Upregulated expressions of both proteins were detected in differentiated EBs. Western blots of b-actin as loading control are
shown. C) miRNAs microarray in EBs cultured for 8 days with ATRA and activin A (DIF EBs) shows a positive fold difference .1.5 for all the family
members of let-7 miRNAs tested (black columns), and in particular a (.9) fold difference for the miRNA let-7e (*) versus EBs cultured for 8 days
without factors (CONTROL EBs). 88 different miRNAs were analyzed, but only the upreglated ones are shown. miRNA expression was normalized to
the average of the four small nuclear housekeeping RNA (snoRNA251, snoRNA202, snoRNA142 and U6 snRNA). The fold difference for each miRNA
was calculated using DDCt method [DDCt =DCt [DIF EBs] – DCt [CONTROL EBs]. D) Northern Blot probed for the mature miRNA let-7e in EBs cultured
for 8 days with ATRA and activin A (DIF) or without factors (CONTROL) confirmed the result of the microarray. Result is graphed in Arbitrary units of
optical density (O.D) n = 36S.D [*] P,0.05 vs. CONTROL.
doi:10.1371/journal.pone.0060937.g001
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[metanephric mesenchyme] increased significantly from day 5 to
day 10 in differentiated EBs compared with non treated EBs
(Fig. 1A). Protein expression of Pax2 and Wt1 also increased in
differentiated EBs compared with non treated EBs (Fig. 1B).
A microRNA microarray was performed on EBs cultured for 8
days under differentiation conditions (he 8th day was selected
based on the high expression of markers found that day). As shown
in table 1, a total of 88 miRNAs were profiled, and a set of 26
miRNA were found upregulated. The expression levels of the
miRNA let-7 family members were significantly upregulated;
[.1.5] fold difference for the eight members (let-7e,let-7i,let-
7a,let-7d,let-7g,let-7c,let-7b,let-7f) in treated EBs with respect the
non treated EBs (Fig. 1C, Table 1). The most upregulated miRNA
with a [.9] fold difference was the miRNA let-7e.
To confirm the results of the microRNA microarray, we
examined expression levels of let-7e miRNA in treated and non
treated EBs by northern blot analysis and additionally by real-time
PCR. As presented in Fig. 1D, miRNA let-7e expression in treated
EBs was dramatically upregulated on day 8 relative to non treated
EBs.
miRNA let-7e Overexpression is Involved in EBs
Expression of Early Nephrogenic Markers
In order to evaluate the role of miRNA let-7e during the EBs
differentiation, let-7e was silenced. Efficient silencing of miRNA
let-7e was observed since expression levels of miRNA let-7e
decreased significantly after silencing (Fig. 2A).
When miRNA let-7e was silenced, mRNA expression of the
differentiation markers WT1, Pax2, Wnt4 were significantly
decreased on day 10 (Fig. 2B), thus indicating the role of miRNA
let-7e in EBs differentiation. Similar results were observed on day
6 (data not shown).
Table 1. Fold Up or Down difference expression of the 88 Microarray miRNAs.







mmu-miR-292-3p 14263.1 mmu-miR-18a 21 mmu-miR-128a 22.83
mmu-let-7e 9.19 mmu-miR-9 21 mmu-miR-185 22.83
mmu-let-7a 5.66 mmu-miR-195 21 mmu-miR-146b 22.83
mmu-miR-144 4 mmu-miR-214 21 mmu-miR-132 23.03
mmu-miR-142-3p 3.73 mmu-miR-21 21 mmu-miR-106a 23.03
mmu-let-7i 3.03 mmu-miR-7a 21.07 mmu-miR-208 23.25
mmu-let-7d 3.03 mmu-miR-26b 21.07 mmu-miR-322 23.73
mmu-miR-125b-5p 2.46 mmu-miR-142-5p 21.07 mmu-miR-503 23.73
mmu-let-7g 2.46 mmu-miR-92a 21.07 mmu-miR-10b 24.92
mmu-miR-15a 2.3 mmu-miR-24 21.07 mmu-miR-378 25.28
mmu-miR-451 2.3 mmu-miR-146a 21.15 mmu-miR-205 25.66
mmu-miR-130a 2.3 mmu-miR-10a 21.15 mmu-miR-20b 26.96
mmu-miR-183 2 mmu-miR-16 21.15 mmu-miR-182 28.57
mmu-let-7c 1.74 mmu-miR-150 21.23 mmu-miR-138 28.57
mmu-miR-103 1.62 mmu-miR-1 21.23 mmu-miR-375 28.57
mmu-miR-23b 1.62 mmu-miR-140 21.23 mmu-miR-101b 29.19
mmu-miR-125a-5p 1.62 mmu-miR-301a 21.23 mmu-miR-320 29.19
mmu-let-7b 1.62 mmu-miR-17 21.23 mmu-miR-370 212.13
mmu-let-7f 1.52 mmu-miR-126-3p 21.32 mmu-miR-488 216
mmu-miR-15b 1.52 mmu-miR-106b 21.41 mmu-miR-345-5p 217.15
mmu-miR-96 1.52 mmu-miR-141 21.41 mmu-miR-541 218.38
mmu-miR-218 1.41 mmu-miR-219 21.32 mmu-miR-122 242.22
mmu-miR-22 1.41 mmu-miR-99a 21.41 mmu-miR-133b 248.5
mmu-miR-155 1.32 mmu-miR-203 21.41 mmu-miR-33 259.71
mmu-miR-222 1.23 mmu-miR-93 21.52 mmu-miR-124 297.01
mmu-miR-429 1.07 mmu-miR-192 21.52 mmu-miR-129-5p 2111.43
mmu-miR-100 21.74 mmu-miR-210 2157.59
mmu-miR-20a 22 mmu-miR-134 2194.01
mmu-miR-137 22 mmu-miR-215 2222.86
mmu-miR-194 22.14 mmu-miR-452 2675.59
mmu-miR-196a 22.64 mmu-miR-223 2955.43
Differentiated sample versus control sample [DIF EBs d8/CONTROL EBs d8].
doi:10.1371/journal.pone.0060937.t001
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In addition miRNA let-7e is an upstream regulator of PKCb
since Western blot analysis of PKCb, revealed a decrease in the
expression in differentiated EBs and an increase when miRNA let-
7e was silenced (Fig. 2C) indicating the inhibitory influence of
miRNA let-7e on PKCb levels.
miRNA let-7e Inhibitory Effect on PKCb Prevents
Phosphorylation of GSK3b and b-catenin Formation
The differentiation treatment applied to embryoid bodies (EBs)
provokes a decrease in GSK3b serine phosphorylation
(GSK3bP])and b-catenin expression compared to EBs control.
Conversely, miRNA let-7e silencing induces an increase in the
expression of GSK3bP and b-catenin, indicating the relation
between miRNA let-7e and Wnt pathway (Fig. 3).
Addition of a PKCb inhibitor to the miRNA let-7e silenced
group reversed the increase in GSK3bP and b-catenin, thus
indicating the direct relationship between PKCb, GSK3bP and b-
catenin levels.
Addition of a PKCb inhibitor to the miRNA let-7e silenced
group reversed the decrease in differentiation markers provoked
previously by let-7e silencing (Fig. 4). The addition of the Wnt
pathway activator BIO to differentiated EBs, decreased the
expression of differentiation markers.
Discussion
In this study we differentiate EBs towards cells that express
markers of intermediate mesoderm and metanephric mesenchyme
using retinoic acid and activin A [9]. After this treatment, we
Figure 2. miRNA let-7e silencing reduces the expression of the differentiation markers WT1, Pax2, Wnt4 and increases the protein
levels of PKCb. Differentiated EBs were collected on day 10 and LNA-antiLet-7e was added on days 7 and 9 of differentiation to collect the cells after
24 h of the last transfection (day 10). Groups: Non treated EBs (CONTROL), differentiated EBs+control antimiR (DIF), differentiated EBs and miRNA let-
7e silenced (DIF-Let-7e). A) RT-PCR of the mature miRNA let-7e confirms that miRNA let-7e is silenced after the administration of antiLet-7e. n = 3.
Data are means6S.D (*) P,0.05 vs. DIF and normalized to U6 snRNA; B) RT-PCR of WT1, Pax2 and Wnt4 show that miRNA let-7e silencing provokes a
downregulation of these genes. Levels were normalized to GAPDH and data represent the mean of three independent experiments 6S.D (*) P,0.05
versus CONTROL, 6S.D (+) P,0.05 versus DIF. C) PKCb levels evaluated by Western blot analysis show a downregulated expression in differentiated
EBs (DIF) and a recovery of the expression in silenced EBs (DIF-Let-7e). Upper panel: Western blot analysis of PKCb. Lower panel: Western blot analysis
of b-actin.
doi:10.1371/journal.pone.0060937.g002
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detected increases in the expression of some differentiation
markers such as Pax2 and WT1, characteristics of the metanephric
mesenchyme and related to the initiation of nephrogenesis [9].
Wnt9b and Wnt4, expressed in the condensing mesenchyme
[10,11], and Notch2, a gen involved in the proximal tubule fate
determination [11] increased significantly during the differentia-
tion protocol. Similar to our results, other authors, using an
identical protocol, differentiated ESCs towards intermediate
mesoderm-like cells. Furthermore, they obtained terminally
differentiated renal cells with the subsequent addition of condi-
tioned medium [9].
Our work indicates that activin A and retinoic acid provokes the
differentiation towards cells that express markers of intermediate
mesoderm and metanephric mesenchyme.
A microarray analysis revealed the overexpression of different
miRNAs in the differentiated EBs compared to control EBs.
Among the miRNAs overexpressed, we found let-7e, let-7i, let-7a,
let-7d, let-7g, let-7c, let-7b and let-7f.
miRNA let-7 family was observed to regulate proliferation and
differentiation of neural stem cells [23]. Here we show that let-7e is
involved in the expression of early nephrogenic markers in
mESCs, since let-7e miRNA silencing reduced the expression of
Pax2, WT-1 and Wnt4, thus indicating the role of let-7e in
differentiation.
PKCb is a multifunctional serine/threonine protein kinase that
plays important roles in the regulation of cell cycle, differentiation
and proliferation [24]. Recently its inhibition has also been
associated with T cell differentiation [25], osteogenic differentia-
tion [26] or cardiomyocyte differentiation [27]. Moreover, the
inhibition of PKCb could block GSK3b serine phosphorylation,
since it has been described that GSK3b phosphorylation by
cholinergic stimulation is probably mediated by a mechanism
involving protein kinase C [PKC], as it was blocked by a PKC
inhibitor [17]. A close relationship between PKCb protein
expression and miRNA let-7e has been detected in our work,
thus miRNA let-7e is an upstream regulator of the PKCb protein
expression. The fact that PKCb has been listed in the micro-
RNA.org database as one potential target gene of the miRNA let-
7e reinforce our findings.
GSK3b constitutively phosphorylates the b-catenin protein and
promotes its degradation. However, serine phosphorylation of
GSK3b provokes the opposite effect and b-catenin degradation is
avoided [28]. Our results show an increased expression of GSK3b
serine phosphorylation and b-catenin, concomitant with a
decrease in the expression of differentiation markers when let-7e
is silenced. Therefore indicates that let-7e acts in differentiation as
an inhibitor of b-catenin through the reduction of the inactive
form of GSK3b.
The use of the PKCb inhibitor Go¨ 6983 that acts avoiding
phosphorylation of several PKC isoforms, including PKCb [29],
provoked a decrease in the Wnt pathway components, GSK3b
serine phosphorylation and b-catenin, concomitant with an
increase in the expression of the differentiation markers, indicating
the relationship between PKCb and Wnt pathway in this process.
Our results indicate that Wnt/b-catenin signalling is reduced in
differentiated EBs. Moreover BIO, an activator of Wnt signaling
pathway [30], reduced the expression of differentiation markers.
In line with our work, it has been described that Wnt signalling
Figure 3. Western blot analysis of GSK3b serine phosphorylation (GSK3bP) (A) and b-catenin (B) in cell lysates of EBs cultured for 10
days. Downregulated expressions of both GSK3bP and b-catenin were detected in differentiated EBs and the expressions were recovered when LNA-
antiLet-7e (DIF-Let-7e) was added. Inhibition of PKCb in the differentiated EBs (DIF-Let-7e+PKCbi) provokes a downregulation again. Western blots of
b-actin as loading controls are shown. n = 3 (*) P,0.05 versus DIF, (+) P,0.05 versus versus DIF-Let7e. Groups: differentiated EBs+control antimiR
(DIF), Non treated EBs (CONTROL), differentiated EBs+LNA-antiLet-7e (DIF-Let-7e), differentiated EBs+LNA-antiLet-7e and PKCb inhibitor (Go¨ 6983)
(DIF-Let-7e+PKCbi).
doi:10.1371/journal.pone.0060937.g003
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activators such as BIO induced the maintenance of pluripotency in
human and mouse embryonic stem cells [14,28] and stimulates
proliferation [31].
In the other hand, Wnt pathway is essential during kidney
development and in cell differentiation toward renal lineage since
it has been shown thatWnt9b2/2mice die within 24 h of birth due
to agenesis of the kidneys [12] and also targeted disruption of Wnt4
results in kidney agenesis and impairs mesenchymal-to-epithelial
transition [32]. Thus it can be argued that activation of the Wnt
pathway should be present in embryonic stem cell differentiation
but in a way in which the end result of b-catenin production is well
balanced in order to avoid pluripotency [31]. This work could well
indicate that one potential interfering factor favoring the correct
balance between Wnt signaling and b-catenin production is the
miRNA let-7e.
In summary, our results indicate that miRNA let-7e is critically
involved in the expression of early nephrogenic markers during
EBs differentiation and the concomitant reduction of b-catenin
production. The inhibitory effect of miRNA let-7e on GSK3b
serine phosphorylation through PKCb could explain these effects.
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Figure 4. RT-PCR of Pax2, Wnt4 and WT1. miRNA let-7e silencing (DIF-Let-7e) and BIO (DIF+BIO) provokes a downregulation of the
genes Pax2, Wnt4 and WT1. Inhibition of PKCb (DIF-Let-7e+PKCbi) provokes a recovery in the expression of these genes. Levels were normalized
to GAPDH and data represent the mean from three independent experiments 6S.D (*) P,0.05 versus DIF, (+) P,0.05 versus DIF-Let7e. Groups:
differentiated EBs+control antimiR (DIF), Non treated EBs (CONTROL), differentiated EBs+LNA-antiLet-7e (DIF-Let-7e), differentiated EBs+LNA-antiLet-
7e and PKCb inhibitor (Go¨ 6983) (DIF-Let-7e+PKCbi), differentiated EBs+BIO (DIF+BIO).
doi:10.1371/journal.pone.0060937.g004
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